* Lifestance Health Group Inc LFST.OQ LFST.O is expected
to show a rise in quarterly revenue when it reports results on
May 9 for the period ending March 31 2024
* The Scottsdale Arizona-based company is expected to
report a
18.4% increase in revenue to $298.991 million from $252.59
million a year ago, according to the mean estimate from 5
analysts, based on LSEG data.
* LSEG's mean analyst estimate for Lifestance Health Group
Inc is
for a loss of 9 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 4
"hold" and 1 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Lifestance
Health
Group Inc is $9.00, above its last closing price of $6.91.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Dec. 31 2023 -0.11 -0.09 -0.12 Missed -29.2
Sep. 30 2023 -0.08 -0.08 -0.17 Missed -112.5
Jun. 30 2023 -0.09 -0.09 -0.13 Missed -50
Mar. 31 2023 -0.11 -0.11 -0.09 Beat 15.1
Jan. -0.13 -0.13 -0.13 Met -1.3
1 0001
Sep. 30 2022 -0.13 -0.14 -0.11 Beat 20.5
Jan. 1 0001 -0.15 -0.14 -0.19 Missed -35.7
Mar. 31 2022 -0.20 -0.17 -0.18 Missed -4.7
This summary was machine generated May 7 at 16:12 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)